92 related articles for article (PubMed ID: 3923140)
1. [Monitoring of follicles by ultrasonography during induction with HMG-HCG treatment--especially on the prevention of side effects].
Ishimaru T; Okamoto S; Kajimura H; Masuzaki H; Huang HJ; Fuchi T; Yamashita T; Imamura S; Imamichi S; Hata T
Nihon Sanka Fujinka Gakkai Zasshi; 1985 May; 37(5):721-9. PubMed ID: 3923140
[TBL] [Abstract][Full Text] [Related]
2. Induction of ovulation in polycystic ovary: human menopausal gonadotropin or human urinary follicle stimulating hormone?
Venturoli S; Paradisi R; Fabbri R; Porcu E; Orsini LF; Flamigni C
Int J Fertil; 1987; 32(1):66-70. PubMed ID: 2880819
[TBL] [Abstract][Full Text] [Related]
3. [A simplified quick semi-quantitative determination of urinary estrogen in non-pregnant female: the application for monitoring of follicular maturation at HMG-HCG therapy].
Kamata S
Nihon Sanka Fujinka Gakkai Zasshi; 1986 Jan; 38(1):64-72. PubMed ID: 3081668
[TBL] [Abstract][Full Text] [Related]
4. Ovulation induction with human menopausal gonadotropins.
Diamond MP; Wentz AC
Obstet Gynecol Surv; 1986 Aug; 41(8):480-90. PubMed ID: 3090489
[TBL] [Abstract][Full Text] [Related]
5. Monitoring of ovulation induction with HMG-HCG therapy by plasma estrogen and progesterone.
Muechler EK; Kohler D; Huang KE
Int J Fertil; 1981; 26(4):273-8. PubMed ID: 6120908
[TBL] [Abstract][Full Text] [Related]
6. Serum 17beta-estradiol. Index of follicular maturation during gonadotropin therapy.
Notation AD; Tagatz GE; Steffes MW
Obstet Gynecol; 1978 Feb; 51(2):204-9. PubMed ID: 622235
[TBL] [Abstract][Full Text] [Related]
7. The role of growth hormone (GH), GH-receptor and GH-binding protein in reproduction and ovulation induction.
Blumenfeld Z; Amit T
J Pediatr Endocrinol Metab; 1996; 9(2):145-62. PubMed ID: 8887137
[TBL] [Abstract][Full Text] [Related]
8. [Monitoring the induction of ovulation by HMG-hCG].
Nahmanovici C
Rev Fr Gynecol Obstet; 1985 Nov; 80(11):809-12. PubMed ID: 2935921
[TBL] [Abstract][Full Text] [Related]
9. [Progress in sterility therapy. Gonadotropin treatment, monitoring follicle maturation using real-time ultrasonics].
Schmidt W; von Holst T
Fortschr Med; 1981 Jul; 99(27-28):1080-6. PubMed ID: 6790397
[TBL] [Abstract][Full Text] [Related]
10. Urinary estradiol-17-beta-glucuronide assay for gonadotropin therapy.
Miyakawa I; Stanczyk FZ; March CM; March AD; Goebelsmann U
Obstet Gynecol; 1981 Aug; 58(2):142-7. PubMed ID: 6789264
[TBL] [Abstract][Full Text] [Related]
11. Ovulation induction by human menopausal gonadotropin with ultrasonic monitoring of the ovarian follicles.
Tulandi T; Hamilton EF; Arronet GH; Coleman PW; McInnes RA
Int J Fertil; 1987; 32(4):312-5. PubMed ID: 2887531
[TBL] [Abstract][Full Text] [Related]
12. Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles.
Papanikolaou EG; Pozzobon C; Kolibianakis EM; Camus M; Tournaye H; Fatemi HM; Van Steirteghem A; Devroey P
Fertil Steril; 2006 Jan; 85(1):112-20. PubMed ID: 16412740
[TBL] [Abstract][Full Text] [Related]
13. Influence of serum progesterone levels at the time of hCG on the release of ova during hMG cycles.
Check JH; Adelson HG; Stern J; Lauer C
Int J Fertil; 1992; 37(2):103-5. PubMed ID: 1349590
[TBL] [Abstract][Full Text] [Related]
14. Methods for monitoring follicle maturation decrease; the ovarian hyperstimulation syndrome during gonadotropin treatment.
Fujita Y; Tasaka K; Miyake A; Aono T; Tanizawa O
Eur J Obstet Gynecol Reprod Biol; 1989 Sep; 32(3):223-5. PubMed ID: 2507369
[TBL] [Abstract][Full Text] [Related]
15. Experience with combined individualized method of hMG/hCG therapy.
Samberg I; Tal J; Zilberman A; Oettinger M; Sharf M
Int J Fertil; 1983; 28(2):85-90. PubMed ID: 6136481
[TBL] [Abstract][Full Text] [Related]
16. HMG-HCG therapy in patients with hypergonadotropic ovarian anovulation: one pregnancy case report and ovulation and pregnancy rate.
Tanaka T; Sakuragi N; Fujimoto S; Ichinoe K
Int J Fertil; 1982; 27(2):100-4. PubMed ID: 6126442
[TBL] [Abstract][Full Text] [Related]
17. [The change of plasma hormonal patterns following gonadotropin therapies (author's transl)].
Matsuoka M
Nihon Sanka Fujinka Gakkai Zasshi; 1982 Feb; 34(2):143-52. PubMed ID: 6801159
[TBL] [Abstract][Full Text] [Related]
18. Plasma hormones in human gonadotropin induced ovulation.
Wu CH
Obstet Gynecol; 1977 Mar; 49(3):308-13. PubMed ID: 840459
[TBL] [Abstract][Full Text] [Related]
19. Persistent ovarian cysts following administration of human menopausal and chorionic gonadotropins: an attenuated form of ovarian hyperstimulation syndrome.
Tummon IS; Henig I; Radwanska E; Binor Z; Rawlins R; Dmowski WP
Fertil Steril; 1988 Feb; 49(2):244-8. PubMed ID: 3123275
[TBL] [Abstract][Full Text] [Related]
20. Luteal phase hyperprolactinemia during ovulation induction with human menopausal gonadotropins: incidence, recurrence, and effect on pregnancy rates.
Tippet PD; Simon JA; Rifka SM; Falk RJ
Obstet Gynecol; 1989 Apr; 73(4):613-6. PubMed ID: 2494621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
